MedPath

Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI

Conditions
Vestibular Schwannoma
Registration Number
NCT03593577
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Endolymphatic hydrops is well known of the lay public in its primary form that is Ménière disease. Nowadays, the best w ay to approach it in vivo, is to use magnetic resonance imaging (MRI).

However, endolymphatic hydrops don't limit itself to its primary form but cover a whole range of pathologies.

The hypothesis is that patients with vestibular schwannomas are more likely to develop secondary saccular hydrops.

The aim is to compare high-resolution T2-weighted images of the saccule in patients followed up for vestibular schwannomas with healthy volunteers and histological sections from cadavers in order to identify its changes.

The secondary purpose of The protocol is to determine if vestibular and audiometric abnormalities could be related to this secondary hydrops more specifically than to the tumor size and localisation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
185
Inclusion Criteria
  • Age> 18,
  • Subject having benefited from an MRI with T2 high-resolution 3D sequence (FIESA) in the context of the diagnosis of vestibular schwannoma between 2008 and 2017 at the University Hospitals of Strasbourg,
  • Subject who has agreed to the use of medical data for the purposes of this research.
Exclusion Criteria
  • Refusal of the patient to participate in the study
  • Insufficient imaging data,
  • Tumors already treated,
  • Atypical tumors with uncertain diagnosis, intra-labrinthic or intra-labyrinthine schwannomas, concomitant infectious or inflammatory pathology in the middle or inner ear.
  • Impossibility of giving the subject informed information (difficulty understanding the subject,)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence or absence of height and width of the saccule on MRI.1 hour after the realization of the MRI
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service Imagerie 1

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath